Oregon/Hawaii Node, Clinical Trials Network

描述（由申请人提供）： 国家药物滥用治疗临床试验网络（CTN）的俄勒冈州/夏威夷节点是一个双向临床试验合作伙伴关系，包括社区治疗计划（CTP）和区域研究和培训中心（RRTC），该中心设在俄勒冈州健康与科学大学（在夏威夷檀香山和俄勒冈州波特兰的凯撒永久健康研究中心的支持下）。位于俄勒冈州、夏威夷和华盛顿州城市和农村社区的8个多模式药物滥用治疗方案参加了该节点：适应（罗斯堡，OR），尾波（波特兰，OR），ChangePoint（波特兰，OR和温哥华，WA），Kaiser Permanente夏威夷行为医学部（檀香山，HI），Kaiser Permanente西北成瘾医学部（塞勒姆和波特兰，OR和朗维尤和温哥华，WA），美洲原住民康复协会，西北（波特兰，OR），新方向西北（贝克市，OR），威拉米特家庭（尤金，OR）。该应用程序有一个具体目标：继续并扩大临床研究伙伴关系，充分参与国家药物滥用治疗临床试验网络，并提供a）有效实施和完成临床试验，包括快速有效地招募研究参与者，B）领导CTN委员会和小组委员会，c）双向研究概念，d）与治疗提供者和其他节点合作出版，以及e）为提高CTN能力的培训和研究建议奠定基础。该节点在试验中招募和保留参与者、质量保证审查、方案培训、参与CTN领导、开发电子病例报告表系统、双向沟通、与其他节点合作以及良好公民身份方面具有高标准。俄勒冈州/夏威夷节点已证明其有能力成为强大而富有成效的CTN成员。

DESCRIPTION (provided by applicant): The Oregon/Hawaii Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) is a bi-directional clinical trial partnership that includes community treatment programs (CTPs) and a Regional Research and Training Center (RRTC) hosted at Oregon Health & Science University (with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii and Portland, Oregon). Eight multi-modality drug abuse treatment programs located in urban and rural communities in Oregon, Hawaii and Washington State participate in the node: Adapt (Roseburg, OR), CODA (Portland, OR), ChangePoint (Portland, OR and Vancouver, WA), Kaiser Permanente Hawaii Department of Behavioral Medicine (Honolulu, HI), Kaiser Permanente Northwest Department of Addiction Medicine (Salem and Portland, OR and Longview and Vancouver, WA), Native American Rehabilitation Association, Northwest (Portland, OR), New Directions Northwest (Baker City, OR), Willamette Family (Eugene, OR). The application has one specific aim: Continue and expand a clinical research partnership that participates fully in the National Drug Abuse Treatment Clinical Trials Network and provides a) effective implementation and completion of clinical trials including rapid and efficient recruitment of study participants, b) leadership to CTN committees and subcommittees, c) bi-directional research concepts, d) collaborative publication with treatment providers and other nodes, and e) a foundation for training and research proposals that enhance CTN capacity. The Node has high standards for participant recruitment and retention in trials, quality assurance reviews, protocol training, participation in CTN leadership, development of systems for electronic case report forms, bi-directional communication, collaboration with other nodes, and good citizenship. The Oregon/Hawaii Node has proven its ability to be a strong and productive CTN member.